Unternehmen
INSERM TRANSFERT SA
INSERM TRANSFERT SA – Unternehmen mit Aktivitäten in Forschung und Innovation.
Forschungsprojekte
- A Coordination and Support Action to prepare UNCAN.eu platform The 15-month coordination and support action “4.UNCAN.eu” will generate a strategic agenda to launch UNCAN.eu…
- Cardiac regeneration by mRNA-triggered proliferation of cardiomyocytes Heart failure (HF) is a major health problem worldwide because of the high number of patients and the related…
- SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients Severe COVID-19 disease and the high frequency of its long-term complications are now a major health problem…
- Building a European strategic Research and Innovation Area in Direct Synergy with EU and International Initiatives for Pandemic Preparedness The COVID-19 pandemic has confirmed and further highlighted the importance of planning and investing in resea…
- Integrated Services for Infectious Disease Outbreak Research The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, pr…
- CArdiovascularREsolution of INflammation to promote HEALTH With 1.9 million deaths and an economic burden estimated to €200 billion each year in Europe, cardiovascular…
- Improving treatment efficacy in hypertension by biomarker-guided personalised decision support In HT-ADVANCE we aim to revolutionise personalised management of arterial hypertension (HT) by using multi-om…
- Early Interception of Inflammatory-mediated Type 2 Diabetes The overall concept of INTERCEPT-T2D is to establish whether an inflammatory-mediated profile contributes to…
- Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease (IBD) Immunotherapy (MITI2) Our project focuses on the regulatory properties of a subset of microbiota-specific TR1-like regulatory T (Tr…
- Fighting childhood obesity to stay healthy all over the life Obesity rates in late teens have increased in Europe from 6% in 1980 to 32%, with long-lasting effects on the…
- Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe) Type 1 diabetes (T1D) is an incurable disease, often starting in childhood, with a risk of devastating compli…
- A clinical research network to improve the management of Monkeypox virus disease The 2022 Monkeypox outbreak is unprecedented in scale and cases are still active in South America and startin…